Daily non-political popular news in brief.

Gene Transfer Using Mutant Form Of Good Cholesterol Cuts Vascular Plaque And Inflammation

09-30-2006 · ScienceDaily

Transfer of a gene that produces a mutant form of good cholesterol provides significantly better anti-plaque and anti-inflammation benefits than therapy using the "normal" HDL gene, according to a mouse study conducted by cardiology researchers at Cedars-Sinai Medical Center and reported in the Oct. 3 issue of the Journal of the American College of Cardiology.

Keywords: gene, transfer, mutant, form, good, cholesterol, cuts, vascular, plaque, inflammation, cut

« Previous | Next »

Similar news on "Gene Transfer Using Mutant Form Of Good Cholesterol Cuts Vascular Plaque And Inflammation":

Augmenting the good cholesterol
04-14-2007 · Science News Online
A reconstituted version of good cholesterol may lessen the amount of plaque that accumulates in arteries and render existing plaque less dangerous.
Similar news · Read more »
p53 gene mutations and inflammation trigger skin cancer
07-02-2007 · EurekAlert!
Squamous cell carcinoma (SCC) is a form of nonmelanoma skin cancer, which is the most common type of human malignancy with over 1 million new cases in the USA each year. In the July 2 issue of the Journal of Clinical Investigation, two separate studies by research teams at Glasgow University and Baylor College of Medicine uncover 2 previously unidentified regulators of SCC development, providing insights into the development of this potentially lethal disease.
Similar news · Read more »
Drug that mimics 'good' cholesterol has mixed effect on coronary atherosclerosis
03-26-2007 · EurekAlert!
The results of a study presented today at the American College of Cardiology’s 56th Annual Scientific Session showed that CSL-111, a drug that mimics HDL, did not significantly reduce plaque in coronary arteries in patients with a recent episode of ACS. However, patients taking the drug showed improvement in two indexes that assess changes in the blood vessels.
Similar news · Read more »
Despite significantly raising HDL, torcetrapib failed to slow the progression of coronary plaques
03-26-2007 · EurekAlert!
Investigators reported today at the American College of Cardiology's 56th Annual Scientific Session that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
Similar news · Read more »
Mutant gene causes severe kidney disease in infants
11-05-2006 · EurekAlert!
Scientists at the University of Michigan Medical School have discovered a previously unknown cause for a severe, early-onset form of kidney disease and renal failure in children: recessive mutations in a gene called phospholipase C epsilon or PLCE1.
Similar news · Read more »
Cancer researchers add spice to research against rare neuromuscular disease
03-20-2007 · EurekAlert!
Scientists have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene. Currently there is no treatment for the inherited disorder, which resembles a slowly progressive form of Lou Gehrig's disease and affects mainly men.
Similar news · Read more »
2 heads are better than 1: 2 dysfunctional DNA repair pathways kill tumor cells
04-12-2007 · EurekAlert!
Individuals who inherit one mutant copy of any one of about 12 genes that make the proteins of the Fanconi Anemia pathway are at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type. However, hope of a new treatment for these cancers has now been provided by a new study indicating that inhibiting the protein ATM can kill these cancer cells.
Similar news · Read more »
Parkinson's mutation stunts neurons
11-22-2006 · EurekAlert!
Mutations in a key brain protein known to underlie a form of Parkinson's disease wreaks its damage by stunting the normal growth and branching of neurons, researchers have found. They have pinpointed the malfunction of the protein made by mutant forms of the gene called LRRK2 and how it affects neurons, ultimately leading to their death.
Similar news · Read more »
JCI table of contents -- March 1, 2007
03-01-2007 · EurekAlert!
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published March 1, 2007, in the JCI, including: Cells in the lung clear the air to prevent lung damage; What makes good cholesterol so “good” for us?; Genetic mutations cause CoQ10 enzyme deficiency; Natural antibodies in newborns recognize a limited spectrum of proteins; and How aldosterone keeps salt in the body.
Similar news · Read more »
Why bad things can happen to the heart when 'good' cholesterol goes bad
08-22-2007 · EurekAlert!
It's yet another example of how a good thing can go bad: Researchers have found evidence in laboratory studies that "good" cholesterol, renowned for its ability to protect against heart disease, can undergo detrimental changes in protein composition that make it "bad" for the heart. The study could lead to new lab tests and treatments for heart disease, they say. It will be presented in August at the American Chemical Society national meeting in Boston.
Similar news · Read more »